ESHG 2013 Booth 136
23 Apr 2013
Croissy-Beaubourg, April 23, 2013 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a CE mark for its proprietary anti-CCP in vitro diagnostic (IVD) kit in rheumatoid arthritis. This test further expands the Fidis portfolio of diagnostic tests for auto-immunes diseases, which significantly decreases [...]
16 Apr 2013
Strong increase in sales of in house products : theranostic range : +56% Tight control over operating costs Cash position of €8.4 million Croissy-Beaubourg, April 16 2013 – THERADIAG (ISIN : FR0004197747, Ticker : ALTER), a company specializing in theranostic and in vitro diagnostic, today reports its audited annual financial results for 2012 as approved by the Board of [...]
11 Apr 2013
We are more than pleased to inform you that we will attend the European Human Genetics Conference 2013 taking place from 8th to 11th June 2013 at the “Palais des congrès” of Paris. The Theradiag team will be delighted to welcome you and look forward to seeing you at its booth no. 136. www.eshg.org/eshg2013
9 Apr 2013
CaReNA, a large scale project for the development of highly innovative RNA-targeting therapeutic and diagnostic solutions in two indications : HIV/AIDS and obesity Croissy-Beaubourg, April 9 2013 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it has been granted financial support by Oséo, the French Agency [...]
15 Feb 2013
Theradiag receives CE mark approval for two new Lisa Tracker monitoring kits in theranostics Croissy-Beaubourg, February 14 2013 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a CE mark for two new biotherapy monitoring kits; Tocilizumab (anti-IL6R) and Rituximab (anti-CD20) that further [...]
17 Dec 2012
We are more than pleased to inform you that we will attend Arab Health taking place from 28th to 31st January 2013 at Dubai International Convention & Exhibition Centre. The Theradiag team will be delighted to welcome you and look forward to seeing you at its booth no. RN 19 located in Rashid Hall (in [...]
12 Dec 2012
Croissy-Beaubourg, 6 December 2012 – Theradiag, a company specializing in theranostics and in vitro diagnostics, announces that, following the Open-Price Offering in France (“OPO”) and the global placement in France and abroad (notably excluding the United States of America) that closed on 4 December 2012, the total number of shares offered was almost twice oversubscribed. [...]
25 Oct 2012
Paris, October 23rd 2012 – Theradiag, the theranostics and in vitro diagnostics company focused on autoimmune diseases, has just signed a partnership agreement with Sebia. Within the framework of this partnership, Theradiag will play an advisory role in development and will be responsible for the scale-up and production of a future diagnostic kit. According to [...]
19 Oct 2012
We are more than pleased to inform you that we will attend the Biology International Days (Journées Internationales de Biologie) taking place the 7th, 8th and 9th of November 2012 at CNIT Paris la Défense. You will be able to meet the Theradiag team at our booth Nr. D16. So you could discover our latest theranostic [...]
1 Oct 2012
We are more than pleased to inform you that we will attend Planet xMAP taking place the 10th and 11th October at Grimaldi Forum in Monaco. For further information on the Congress, please visit the website www.planetxmap.com. The Theradiag team will be delighted to welcome you at its booth.